Tecan Group AGTCHBF 76 Beneish M-Score is -3.39 as of Jul. 05, 2026. GuruFocus rates TCHBF with a GF Score™ of 76/100 and a GF Value™ of $273.48 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 764 Medical Devices & Instruments companies, Tecan Group AG ranks better than 87.04% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -3.39 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for Tecan Group AG's Beneish M-Score or its related term are showing as below:
TCHBF'
s Beneish M-Score Range Over the Past 10 Years
Min: -3.39 Med: -2.53 Max: -1.75
Current: -3.39
During the past 13 years, the highest Beneish M-Score of Tecan Group AG was -1.75. The lowest was -3.39. And the median was -2.53.
Tecan Group AG Beneish M-Score Related Terms
Tecan Group AG Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Tecan Group AG's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TCHBF vs ISRG, BDX, MDLN: Beneish M-Score Comparison
For the Medical Instruments & Supplies subindustry, Tecan Group AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tecan Group AG Beneish M-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Tecan Group AG's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Tecan Group AG for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 0.8953
+
0.528 * 0.9742
+
0.404 * 0.954
+
0.892 * 1.0568
+
0.115 * 0.9912
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 1.1555
+
4.679 * -0.146417
-
0.327 * 1.0496
=
-3.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(74.927 / (74.927 + 165.24))
/
(76.538 / (76.538 + 166.628))
=
0.311979
/
0.314756
=
0.9912
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(-138.854 - 0
-
173.141)
/
2130.868
=
-0.146417
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Tecan Group AG has a M-score of -3.29 suggests that the company is unlikely to be a manipulator.
Tecan Group AG (TCHBF) has a Beneish M-Score of -3.39 as of Jul. 05, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Tecan Group AG and its competitors. According to the industry distribution chart, Tecan Group AG ranks #99 out of 764 companies in the Medical Devices & Instruments industry, placing it in the top 13%.
Is Tecan Group AG's Beneish M-Score too high?
Tecan Group AG's current Beneish M-Score is -3.39. Based on the distribution chart, Tecan Group AG ranks #99 out of 764 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Tecan Group AG has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tecan Group AG's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tecan Group AG ranks #99 out of 764 companies for Beneish M-Score. This places Tecan Group AG in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Tecan Group AG and its competitors. Tecan Group AG's current Beneish M-Score is -3.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tecan Group AG stock overvalued right now?
Based on GuruFocus' analysis, Tecan Group AG (TCHBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $273.48, compared to a current price of $198.00 — trading 27.6% below its estimated fair value. The current Beneish M-Score is -3.39. Tecan Group AG's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Tecan Group AG (TCHBF), the current Beneish M-Score is -3.39 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tecan Group AG (TCHBF) Overvalued in 2026?
Based on GuruFocus' analysis, Tecan Group AG stock appears to be undervalued.
The current stock price of $198.00 is trading 27.6% below its estimated GF Value™ of $273.48.
GuruFocus considers Tecan Group AG to be Significantly Undervalued.
Key valuation signals for TCHBF:
Beneish M-Score: -3.39
GF Value™: $273.48 vs. price of $198.00 (27.6% below fair value)
No single metric tells the full story. See the TCHBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
76GF Score
Get the complete analysis for TCHBF
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TCHBF has been successfully added to your 
